Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1947 of 5804
-
New scan could reveal how well your immune system fights cancer
Diagnosis Recruiting nowThis study is researching an experimental drug called 89Zr-DFO-REGN5054 and cemiplimab. The study is focused on patients with a type of cancer that can be potentially imaged using 89Zr-DFO-REGN5054 and show special tumor features that may be important to the way the immune system…
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Diagnosis
Last updated Jun 26, 2026 15:38 UTC
-
Stem cell eye drops aim to heal stubborn corneal defects
Disease control TerminatedThe primary objective of the study is to investigate the safety and efficacy of KPI-012 compared to vehicle in participants who have a documented clinical diagnosis of PCED.
Phase: PHASE2 • Sponsor: Combangio, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Robot companions fight apathy in Alzheimer's patients
Symptom relief CompletedThe objective of this study is to demonstrate the impact of a socially assistive robot system on reducing apathy among cognitively impaired older adults residing in long term care facilities. Earlier phases of this project demonstrated the feasibility and acceptability of the rob…
Phase: PHASE1, PHASE2 • Sponsor: Vanderbilt University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Heart surgery antibiotic duration under scrutiny: could one dose be enough?
Disease control Recruiting nowThis multicentre, adaptive, pragmatic, double-blind, three-arm, placebo-controlled, randomised, non-inferiority clinical trial will compare the incidence of surgical site infection and other healthcare associated infections, health economic and microbiological impact after intrao…
Phase: PHASE4 • Sponsor: Monash University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New antifungal drug shows promise against deadly fungal infections
Disease control CompletedThis study is a post-approval commitment study, and is designed to further evaluate the safety and efficacy of isavuconazole in a relatively larger Chinese population who will receive isavuconazole treatment in a post-marketing setting. This is a single arm, prospective, multi-c…
Phase: PHASE4 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
CPAP may tame blood pressure in sleepy sleep apnea patients
Disease control OngoingThe primary objective of this study is to determine the longer-term (6 months) effect of CPAP therapy on change in 24-hour mean blood pressure (24hMBP) in OSA subjects with the excessively sleepy symptom subtype.
Sponsor: Ohio State University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can common painkillers replace opioids after surgery?
Symptom relief Recruiting nowThis trial is being completed to compare two commonly used options to treat pain after surgery. Participants that undergo gallbladder removal, hernia repair, and breast lump removal will be eligible to enroll. Eligible participants will be randomized to 1 of 2 groups of medicatio…
Phase: PHASE4 • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Stand up to beat diabetes: new study tests desk hack
Disease control Recruiting nowMore than 84 million - or 1 out of every 3 U.S. adults - have prediabetes, a condition that if not treated often leads to type 2 diabetes within five years. Average medical expenditures among diabetics are about 2.3 times higher than expenditures for people without diabetes. Phys…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New study tests cheaper vs. fancier care for high blood pressure in HIV patients
Disease control CompletedEffective, cost-effective, scalable, sustainable, and equitable implementation strategies to improve care for people living with HIV and co-morbid hypertension in sub-Saharan Africa are urgently needed. Our study will compare the effectiveness, scalability, and cost-effectiveness…
Phase: NA • Sponsor: Infectious Diseases Research Collaboration, Uganda • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New glasses could help Kids' eyesight stop getting worse
Disease control OngoingThis is a randomized, controlled, evaluator-blinded, multicenter, two-arm parallel group clinical trial to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses by comparing to single vision, impact-resistant spectacle lenses in reducing…
Phase: NA • Sponsor: SightGlass Vision, Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Exercise after cancer: could resistance training rebuild bodies?
Disease control Recruiting nowThis protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements under close supervision on individuals who have been treated for cancer.
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a natural hormone help restore fertility?
Disease control Recruiting nowThe goal of this study is to see whether kisspeptin, a naturally occurring hormone, can stimulate the release of other reproductive hormones in men and women with idiopathic hypogonadotropic hypogonadism (IHH). The investigators are also examining whether kisspeptin can help wome…
Phase: PHASE2 • Sponsor: Stephanie B. Seminara, MD • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for chinese HLH patients: emapalumab shows promise
Disease control CompletedThe goal of this post-authorization study is to describe safety and efficacy of emapalumab in treatment experienced Chinese patients with pHLH.
Phase: PHASE4 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New heart failure drug shows promise in Mid-Stage trial
Disease control TerminatedThe main purpose of this study is to assess the efficacy and safety of LY3540378 in adults with worsening heart failure with preserved ejection fraction
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Joystick training may help veterans fight alcohol cravings
Disease control Recruiting nowThe proposed study will test a novel treatment for alcohol use disorders (AUD) to determine if it helps Veterans reduce their hazardous drinking and recover from alcohol-related functional impairments across social, occupational, and domestic domains. To do so, the investigators …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New heart test could predict sudden cardiac death risk
Diagnosis Recruiting nowCalcium Release Deficiency Syndrome (CRDS) is a novel inherited arrhythmia syndrome secondary to RyR2 loss-of-function that confers a risk of sudden cardiac death. Diagnosis of CRDS presently requires cellular-based in vitro confirmation that an RyR2 variant causes loss-of-functi…
Phase: NA • Sponsor: Population Health Research Institute • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
CRISPR Gene-Edited immune cells aim to fight lung cancer – but trial never started
Disease control TerminatedA clinical trial to assess the safety and efficacy of genetically-engineered Tumor Infiltrating Lymphocytes (TIL) in which the intracellular immune checkpoint CISH has been inhibited using CRISPR gene editing for the treatment of Metastatic Non-small Cell Lung Cancer (NSCLC).
Phase: PHASE1, PHASE2 • Sponsor: Intima Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Weekly shot may help short kids grow – new study underway
Disease control OngoingThe purpose of this study is to find out if somapacitan is safe and how well somapacitan works in children either born small for gestational age or with Turner syndrome, Noonan syndrome or idiopathic short stature. Somapacitan is a new growth hormone medicine for treatment of low…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New remote monitoring system aims to keep blood sugar patients out of the ER
Disease control CompletedPatients who have experienced dysglycemia in hospital (either from diabetes, post-solid organ transplantation, medication titration, or other causes) may struggle to manage their blood glucose when discharged home. This may lead to ER visits or readmissions that could have been p…
Phase: NA • Sponsor: DexCom, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a common heart drug ease ulcerative colitis?
Disease control CompletedStatins exert numerous pleiotropic effects including anti-inflammatory, antioxidant properties, endothelial function improvement, and immunomodulation independent of their basic lipid-lowering properties.
Phase: PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC